Categories are established for use in physiological monitoring devices and these categories are prioritized such that data indicative of a critical event self-triggers a communication to an external receiver for the purpose of re-transmitting the critical data for use by a clinician. The categories can be established by the clinician and, if desired, the precise monitored data parameters can be assigned to specific categories. Far-field transmission can be used to send certain stored data to an external receiver, provision is made for externally charging the device batteries.
|
1. An implantable device for recording physiological waveforms, the device comprising:
electronic circuitry for sampling a physiological waveform of a patient;
memory for storing physiological data;
a processor under the control of executable instructions for processing samples of the physiological waveform, wherein the processor is programmed (i) to detect a predefined event in the physiological waveform by analyzing the physiological waveform against multiple parameters with each of the multiple parameters applied to a different segment of the physiological waveform and (ii) to store physiological data in the memory in response to detection of the predefined event, wherein the processor executes a diagnostic routine to identify locations in the memory that consume an amount of current above a threshold value during write memory transactions and the processor avoids storing the physiological data in the identified locations; and
a wireless communication module for communicating with a device external to the patient after the implantable device has been implanted in the patient.
2. The implantable device of
3. The implantable device of
4. The implantable device of
5. The implantable device of
6. The implantable device of
7. The implantable device of
8. The implantable device of
9. The implantable device of
10. The implantable device of
11. The implantable device of
12. The implantable device of
13. The implantable device of
14. The implantable device of
|
The present application claims the benefit of U.S. Provisional Application Ser. No. 60/603,474, filed Aug. 20, 2004, entitled “PHYSIOLOGIC EVENT MONITORING DEVICE,” and U.S. Provisional Application Ser. No. 60/603,529, filed Aug. 20, 2004, entitled “PHYSIOLOGIC EVENT MONITORING DEVICE HAVING ROBUST INTERNAL CONTROL,” which are incorporated herein by reference.
The present application is generally related to implantable medical devices that monitor for events in patients.
A number of products exist for implantation within a patient with minimally invasive intrusion to monitor for one or several physiologic events. An example of such a device is described in U.S. Pat. No. 5,987,352 issued Nov. 16, 1999. The device shown in the above-described patent is enclosed within a rigid shell. The shell is somewhat cylindrical. One electrode is disposed at one end of the shell and another electrode is disposed on the other end of the shell. The two electrodes are used to measure an electrical waveform in the body (e.g., ECG signals). The waveform is sampled and the sampled data is stored within memory of the device. An external device can be positioned on the patient's body immediately above the monitoring device to enable the external device to retrieve the stored data for subsequent analysis by a clinician.
One embodiment of the present invention is an implantable device for recording physiological waveforms, the device comprising an electronic circuitry for sampling a physiological waveform of a patient, a memory for storing physiological data, a processor under the control of executable instructions for processing samples of the physiological waveform, wherein the processor is operable (i) to detect a predefined event in the physiological waveform by analyzing the physiological waveform against multiple parameters with each of the multiple parameters applied to a different segment of the physiological waveform and (ii) to store physiological data in the memory in response to detection of the predefined event; and a wireless communication module for communicating with a device external to the patient after the implantable device has been implanted in the patient.
In some embodiments, multiple triggers are used to identify physiological data to be stored within the memory of a monitoring device. When the physiological data is stored, the particular trigger is identified by tagging the data with an appropriate identifier. By tagging or otherwise suitably identifying the trigger, some embodiments enable the stored data to be managed and/or analyzed in an efficient manner. Stored data can be prioritized according to a physician's requirements. If the stored data exceeds the memory capacity of the monitoring device, the monitoring device does not overwrite physiological data associated with higher priority triggers with physiological data associated with lower priority triggers. Additionally, even if the memory of the device is not exceeded, the tagging functionality of the monitoring device enables the most relevant data to be retrieved and reviewed by a clinician in an efficient manner, i.e., the clinician can identify and retrieve data pertaining to one or several specific triggers. In some embodiments, the trigger functionality can be controlled by the clinician in a more accurate manner by utilizing “signature references.” Multiple signature references can also be applied to physiological data. The reference signatures can be applied in combination with one or several conventional static trigger criteria. In some embodiments, the signature references are applied in a time dependent manner. For example, a subset of signature references could be employed during daytime hours and another subset of signature references could be employed during nighttime hours.
In some embodiments, the monitoring device includes a self-diagnostic software module that analyzes the memory of the monitoring device used to store the physiological data. Specifically, the software module can write known values to memory locations in the memory and retrieve the known values from the memory locations. When the retrieved values deviate from the expected values, defective memory locations can be identified. In addition, other types of memory defects can be identified. For example, certain memory defects can cause writing to and/or reading from a particular memory location to consume an undue amount of current and thereby more readily deplete battery power. Accordingly, some embodiments monitor the amount of current associated with each write/read transaction to detect such memory defects. By maintaining a table of defective memory locations, the monitoring device can avoid using such locations to maintain the integrity of the physiological data and to maintain the battery capacity of the device. In other embodiments, a suitable error correction code (ECC) scheme (e.g., a Reed-Solomon code correction algorithm) is additionally applied to the physiological data to maintain the integrity of the physiological data
In some embodiments, the monitoring device operates in conjunction with an external patient communicator device. The patient communicator device can be kept on the person of the patient (on a belt, in a pocket, etc.). When an event of interest is detected and recorded by the monitoring device, the monitoring device signals the patient communicator device using far field wireless communication. The signal causes the patient communicator device to alert the patient. The patient can then take suitable action (e.g., seek suitable medical attention, allow the stored data to be communicated to an appropriate medical professional, etc.). The patient communicator device can also be used to communicate suitable parameters (e.g., signature references, priority information, etc.) to the monitoring device to control the operations of the monitoring device. The patient communicator device can also obtain status information from the monitoring device such as battery status, remaining memory capacity, detected event types, and/or the like. The patient communicator device can be implemented to perform other functions. For example, the patient communicator can include a USB port or other suitable interface to connect to digital devices to facilitate the communication of the stored physiological data to appropriate medical personnel. The USB port can also be used to charge the patient communicator device. Additionally, the patient communicator device can include a suitable coil to radiate RF power to the monitoring device to recharge the monitoring device.
The foregoing has outlined rather broadly the features and technical advantages of some embodiments in order that the detailed description that follows may be better understood. Additional features and advantages will be described hereinafter which form the subject of the claims of the invention. It should be appreciated that the conception and specific embodiments disclosed may be readily utilized as a basis for modifying or designing other structures for carrying out the same purposes of the present invention. It should also be realized that such equivalent constructions do not depart from the invention as set forth in the appended claims. The novel features, both as to its organization and method of operation, together with further objects and advantages will be better understood from the following description when considered in connection with the accompanying figures. It is to be expressly understood, however, that each of the figures is provided for the purpose of illustration and description only and is not intended as a definition of the limits of the present invention.
Implantable monitoring devices are currently used to monitor various physiological parameters in a patient. For example, the Reveal® product from Medtronic monitors a patient's cardiac activity over a period of time, collects information relating to a specific cardiac event, and transfers such information to a physician for evaluation. Such devices, however, can be used to monitor a wide range of medical conditions such as diabetes, respiratory function, kidney function, brain function and most other medical or physiological conditions.
These implantable monitoring systems balance size and functionality. Because the systems are implanted and used for diagnostic purposes, the devices should be small enough to be subcutaneously implanted (perhaps during a visit to a doctor's office or outpatient visit) and provide long term monitoring capabilities to ensure that the necessary medical events for diagnosis are captured and recorded. Certain embodiments of the present invention provide of a design that allows it to balance its small size with increased diagnostic monitoring and recording capabilities, providing physicians with greater information.
Although existing implantable monitoring devices can monitor physiologic events in some circumstances, existing monitoring devices are limited in a number of respects. For example, existing monitoring devices merely store physiologic data when a very simple “trigger” event occurs, i.e., heart rate exceeding a specified level. However, the use of such rudimentary criteria can omit detection of important physiologic events and can misidentify normal events. Additionally, failed memory elements within the monitoring devices can cause the stored physiological data to substantially reduce the value of the retrieved data for analysis by a clinician. Furthermore, the amount of data associated with multiple trigger events can exceed the memory capacity of known devices. Accordingly, previously stored data can be overwritten by data associated with a more recent trigger event in existing monitoring devices. However, the overwritten data can be of significantly greater relevance than the data associated with the more recent trigger event.
Prior art implantable monitoring devices are described in U.S. patent application Ser. No. 08/678,219, which has issued as U.S. Pat. No. 5,987,352 and its progeny. These devices are otherwise known to those in the art as implantable loop recorders or ILRs. An example of an ILR is the Reveal® Plus, sold by Medtronic. These devices are small and placed subcutaneously above the heart in the left chest area. Such devices are relatively simple in that they monitor cardiac activity for only one specific anomaly. Once the device recognizes the anomaly, the monitor will record the cardiac event correlating to the anomaly using a “loop recording” design.
In some embodiments of the present invention, multiple triggers are used to cause physiological data to be stored within the memory of a monitoring device. When the physiological data is stored, the particular trigger is identified by tagging the data with an appropriate identifier. By tagging or otherwise suitably identifying the trigger, some embodiments enable the stored data to be managed and/or analyzed in an efficient manner. For example, according to some embodiments, programmable prioritization parameters are used by the monitoring device to allocate memory for the various categories of physiological data. Specifically, a clinician may believe that a particular trigger is especially relevant to the observed symptoms of the patient. The clinician can use the parameters to indicate that the particular trigger possesses the highest priority. After the parameters are set in this manner, if the stored data exceeds the memory capacity of the monitoring device, the monitoring device does not overwrite physiological data associated with higher priority triggers with physiological data associated with lower priority triggers. Additionally, even if the memory of the device is not exceeded, the tagging functionality of the monitoring device enables the most relevant data to be retrieved and reviewed by a clinician in an efficient manner, i.e., the clinician can identify and retrieve data pertaining to one or several specific triggers.
In some embodiments, the trigger functionality can be controlled by the clinician in a more accurate manner by utilizing “signature references.” The signature references are multiple parameters that are indicative of physiologic waveform characteristics. In some embodiments, the signature references are multi-point reference targets with tolerable variations. The multi-point reference targets are compared against multiple points of the monitored waveform. If the physiological event deviates from one of the point targets by the corresponding variation parameter, the data associated with the physiological event is stored and preferably tagged. Multiple signature references can also be applied to physiological data. The reference signatures can be applied in combination with one or several conventional static trigger criteria. In some embodiments, the signature references are applied in a time dependent manner. For example, a subset of signature references could be employed during daytime hours and another subset of signature references could be employed during nighttime hours.
In some embodiments, the monitoring device includes a self-diagnostic software module that analyzes the memory of the monitoring device used to store the physiological data. Specifically, the software module can write known values to memory locations in the memory and retrieve the known values from the memory locations. When the retrieved values deviate from the expected values, defective memory locations can be identified. In addition, other types of memory defects can be identified. For example, certain memory defects can cause writing to and/or reading from a particular memory location to consume an undue amount of current and thereby more readily deplete battery power. Accordingly, some embodiments monitor the amount of current associated with each write/read transaction to detect such memory defects. By maintaining a table of defective memory locations, the monitoring device can avoid using such locations to maintain the integrity of the physiological data and to maintain the battery capacity of the device. In other embodiments, a suitable error correction code (ECC) scheme is additionally applied to the physiological data to maintain the integrity of the physiological data.
In some embodiments, the monitoring device operates in conjunction with an external patient communicator device. The patient communicator device can be kept on the person of the patient (on a belt, in a pocket, etc.). When an event of interest is detected and recorded by the monitoring device, the monitoring device signals the patient communicator device using far field wireless communication. The signal causes the patient communicator device to alert the patient. The patient can then take suitable action (e.g., seek suitable medical attention, allow the stored data to be communicated to an appropriate medical professional, etc.). The patient communicator device can also be used to communicate suitable parameters (e.g., signature references, priority information, etc.) to the monitoring device to control the operations of the monitoring device. The patient communicator device can also obtain status information from the monitoring device such as battery status, remaining memory capacity, detected event types, and/or the like. The patient communicator device can be implemented to perform other functions. For example, the patient communicator can include a USB port or other suitable interface to connect to digital devices to facilitate the communication of the stored physiological data to appropriate medical personnel. The USB port can also be used to charge the patient communicator device. Additionally, the patient communicator device can include a suitable coil to radiate RF power to the monitoring device to recharge the monitoring device.
As shown in
In the embodiments of
If desired, there could be several different lengths of probe 12 (or probe 12 could be expandable) each to accommodate different size patients. Expansion of probe 12 could be by a screw type turnbuckle, by sections fitting inside sections much like a drapery rod or by such other mating systems as is known in the implantable medical device art. Housing 11 would typically be constructed from solid material, but it could be flexible. In one embodiment, probe section 12 could be flexible to facilitate alignment with the shape or motion of the body and could be relatively thin in both the y and z planes. A flexible probe 12 provides for a comfortable design for the patient. Prior art designs provide for a “one size fits all.” However, it is known that all patients are not built the same. Thus, having a flexible probe allows the probe to conform to the shape of the patient's incision site. Also, having a removable probe allows the implanter to choose the proper length of probe 12 based on the patient's size. However, it is important to note that other embodiments might have a permanently attached or non-flexible probe (or any combination of the two). Moreover, the design of device 10 is advantageous, because the design enables device 10 to include more elements to provide a greater amount of functionality (e.g., processing capability, battery recharging, etc.).
In one embodiment, not shown, the width (y) of probe 12 could be narrower even than sensor 14, with sensor 14 supported at the end thereof. Note that several probes 12 could be added to a single housing, each having a sensor placement in close proximity to a potential source of physiological waveforms generated by a human body. The sensors are connected by wires or other suitable conductors, not shown, to the electronics contained in housing 11. Appropriate suture holes 15 can be positioned in device 10, if desired, to facilitate maintaining the device in a proper orientation once implanted. Note that the flat area of housing 11 will prevent device 10 from turning over even if the probe section is tubular, as shown in
The rechargeability of device 10 in combination with other functionality of device 10 enables device 10 to operate in a manner that is fundamentally different than conventional implantable monitoring devices. Specifically, conventional monitoring devices are merely hardware-based circuitry coupled to memory that record physiological data when a defined physical parameter exceeds or falls below some threshold value. The power requirements of such hardware-implemented devices are quite minimal. Thus, there is no benefit of integrating battery recharging functionality in hardware-implemented devices. In contrast, as discussed below, device 10 preferably implements a number of relatively sophisticated algorithms to analyze, process, and communicate physiological data using a microprocessor. To support the processor and software algorithms, a greater amount of power is consumed than conventional hardware-implemented systems. Additionally, for some patients and conditions, it may be appropriate to monitor the patient for up to eighteen months or longer. A battery for supporting the processor and algorithms over this length of time would cause the monitoring device to be of undue size. Alternatively, a smaller battery would likely run out of power and require explanation of the device. Accordingly, some embodiments enable sophisticated monitoring of physiological processes over relatively long periods of time without requiring undue device size and without requiring an explanation procedure to replace the battery of the monitoring device.
The sensor functionality (depicted as sensors 13 and 14 in
As previously mentioned, device 10 preferably captures data for a plurality of categories of events and prioritizes among those events.
The prioritization of the categories of data can be used for several purposes. In one embodiment, device 10 implements algorithms to facilitate the management of the physiological data in memory 32. For example, device 10 can be implemented to store sets of physiological data in file structures in memory 32. Suitable metadata is associated with the various files to indicate one or several events associated with the physiological data of each file. The metadata could be stored as one or several tag data structures within a header that immediately precedes each set of physiological data. Alternatively, an index structure can be used to identify the event(s) corresponding to each set of physiological data. When the amount of stored physiological data reaches the capacity of memory 32, processor 31 examines the priority levels of the various categories before overwriting any stored data with data associated with a more recent event. Processor 31 preferably overwrites the lowest priority set(s) of physiological data (if overwriting is necessary). If the more recent event is of lower priority than all of the stored sets of physiological data, processor 31 preferably omits storing the data associated with the more recent event.
The metadata identifying the events associated with the sets of physiological data can be used for other purposes. For example, a clinician may communicate a command, using communicator device 36 or otherwise, to obtain data related to a specific category of event. Device 10 processes the command by transmitting each set of physiological data associated with the specific category of event. Thereby, the clinician can obtain the desired data without requiring the device 10 to output all data stored in memory 32. The metadata also is useful in reducing the amount of information needed to store the physiological data. In particular, because the metadata allows multiple events to be associated with each set of physiological data, duplicate recording need not be stored per event as is exhibited by known monitoring devices.
Prioritization schemes can be used for multiple purposes. For example, the stored physiological data is preferably communicated to patient communicator device 36 and subsequently to a clinician in accordance with the priority levels, i.e., highest priority level data is communicated first. In other embodiments, the priority level of an immediately occurring event can be communicated to patient communicated device 36. Depending upon the communicated priority level, patient communicator 36 may provide a different type of warning signal to the patient. If the priority level is relatively low, the signal can merely indicate to the patient that the patient should allow the physiological data to be communicated to a clinician within the near future. Alternatively, if the priority level is relatively high, the signal can indicate to the patient that the patient should seek immediate medical attention. Depending upon the intended application of the device, the prioritization scheme for warning the patient can be implemented independently of the prioritization scheme associated with the memory management of device 10.
In some embodiments, reference signatures are applied to the analysis of physiological waveforms. In essence, the reference signatures enable physicians to define waveform characteristics to which pattern matching analysis is applied against the physiological waveform of the patient. The reference signatures preferably define multiple point reference targets (e.g., 4-6) with tolerable variations (e.g., 15-30%). If the measured physiological waveform deviates from the reference targets beyond the tolerable variations, a trigger is generated and data recordation occurs.
For example, the physiological waveform for ECG signals includes a “P wave,” a “QRS complex,” and a “T wave.” The signal processing of monitor device 10 preferably identifies each segment and determines the relevant characteristics of the segments (e.g., the segment lengths, segment amplitude, polarization, etc.). The reference signature can define amplitude parameters, timing parameters, or other suitable parameters for one or several of these relevant characteristics. Also, the timing parameters of a reference signal can involve the timing of the individual segments and/or the timing relationships between the segments. By providing such functionality, a physician can more accurately define a monitoring regimen adapted for a particular patient. Additionally, static conventional trigger criteria can be used in combination with the reference signatures in some embodiments.
In addition to performing memory management according to a prioritization scheme, device 10 preferably selectively stores data in memory 32 according to known locations of memory defects in memory 32.
In step 704, the relevant data is stored in memory 32 of monitoring device 10. The data is preferably stored subject to the prior detection of defective memory locations. Additionally, if the memory capacity has been reached, the data storage preferably occurs according to event prioritization. In some embodiments, a compression scheme is applied to the physiological data stored in memory 32 of monitoring device 10. Although the data storage is depicted after the receipt of data in the flowchart, it shall be appreciated that, when the flowchart is implemented in software, the data storage occurs concurrently with the receipt of data. In step 705, the stored data is tagged with suitable metadata to identify the event(s) associated with the data.
In step 706, an attempt is made to establish a wireless communication connection with patient communicator device 36 using a suitable wireless communication protocol. If a communication connection is established, the monitoring device communicates a signal to the patient communicator that one or several events of interest have occurred. In step 707, the patient communicator provides a suitable signal or alarm to alert the patient. The external alarm could be audible to the patient, a mechanical vibration, a flashing light, a display of text with instructions for the patient, or any suitable combination of thereof.
Additionally, in step 708, monitoring device 10 communicates the physiological data to the patient communicator device for storage therein. The communicated physiological data can be deleted from memory 32 upon successful communication to the patient communicator device. Alternatively, the physiological data can be temporarily retained in memory and subsequently deleted when memory capacity is needed for other data. In some embodiments, the physiological data is transferred from monitoring device 10 to patient communicator device 36 in a compressed format. The data is preferably subsequently decompressed by a software module of a computer when patient communicator device 36 is coupled to the computer.
The decompressed physiological data is formatted in a suitable manner by the software module on the computer (step 709). The physiological data can be formatted as time-samples of the physiological waveform. In one embodiment, an image or video file is created that graphically depicts multiple cycles of the ECG waveform of the patient (in addition to or in lieu of the raw digital samples). Additional information is preferably included within the image(s). For example, patient identification information can be included therein. Additionally, portions of the ECG waveform exhibiting aberrant characteristics can be automatically identified (e.g., rendered using a color different from the color used to render other parts of the waveform). The particular trigger event(s) associated with the physiological data can be identified in the image(s). In step 710, the formatted physiological data is communicated to a suitable clinician. In one embodiment, the created file is attached to an e-mail and communicated to an identified e-mail address. The e-mail can contain suitable information (e.g., patient identification, trigger event(s), time of occurrence, etc.). In alternative embodiments, formatting of the file(s) can be performed by the patient communicator device. For example, the patient communicator device can store the formatted images file in its memory and the stored files can be retrieved by a computer via the USB interface using conventional file operations.
The described communication of physiological data to and from a clinician occurs in a substantially more efficient manner than known monitoring devices. Specifically, known monitoring devices communicate physiological data over a phone line to a specialized service via a modem. The process for communicating physiological data by known monitoring devices is cumbersome for the patient and also unduly time consuming for the clinician. In contrast, some representative embodiments place a relatively light burden on the patient (i.e., the patient need only connect the patient communicator to an Internet-enabled computer). Moreover, the clinician may access the physiological data in an efficient manner and analyze data in a convenient format.
According to one embodiment,
If one or several new e-mails are identified (step 902), the corresponding data contained therein is read (step 903). A logical comparison is made upon whether the new data should be processed by an analysis routine (step 904). The system could be configured so that all incoming data is analyzed or only data satisfying certain criteria is reviewed. In step 905, the received data is analyzed. During the analysis, the received data is compared to the previously received data received to identify a possible relevant trend in the patient (e.g., deterioration of the patient's condition). Any number of other analysis algorithms could be employed at this step. In addition to autonomous analysis by computer-implemented algorithms, physician or other clinician review of the data can be performed at this step.
In step 906, based partially (or entirely) on the results of step 905 and partially (or entirely) under control of the caregiver, a change to a trigger value, a priority code, or other value (or any other changes to the implanted patient device) is made. This “revision” data is packaged as part of an e-mail (either imbedded therein or as an attachment) and the e-mail is sent to the patient's computer (step 907). Once received by the patient's computer, the patient communicator device 36 extracts the data from the e-mail and subsequently communicates the revision data to monitoring device 10. Monitoring device 10 modifies its operations according to the revision data.
Although the present invention and its advantages have been described in detail, it should be understood that various changes, substitutions and alterations can be made herein without departing from the invention as defined by the appended claims. Moreover, the scope of the present application is not intended to be limited to the particular embodiments of the process, machine, manufacture, composition of matter, means, methods and steps described in the specification. As one will readily appreciate from the disclosure, processes, machines, manufacture, compositions of matter, means, methods, or steps, presently existing or later to be developed that perform substantially the same function or achieve substantially the same result as the corresponding embodiments described herein may be utilized. Accordingly, the appended claims are intended to include within their scope such processes, machines, manufacture, compositions of matter, means, methods, or steps.
Patent | Priority | Assignee | Title |
10653336, | Jun 27 2014 | Intel Corporation | Subcutaneously implantable sensor devices and associated systems and methods |
7756573, | Sep 05 2006 | Cardiac Pacemakers, Inc | Implantable medical device diagnostic data acquisition and storage |
7764988, | Apr 27 2006 | Medtronic, Inc.; Medtronic, Inc | Flexible memory management scheme for loop recording in an implantable device |
8200324, | Sep 05 2006 | Cardiac Pacemakers, Inc. | Implantable medical device diagnostic data acquisition and storage |
8514067, | Aug 16 2011 | Elwha LLC | Systematic distillation of status data relating to regimen compliance |
8578118, | Apr 26 2007 | Medtronic, Inc.; Medtronic, Inc | Scheme for overwriting stored physiological data in an implantable medical device |
8599009, | Aug 16 2011 | Elwha LLC | Systematic distillation of status data relating to regimen compliance |
8704688, | Sep 05 2006 | Cardiac Pacemakers, Inc. | Implantable medical device diagnostic data acquisition and storage |
8723640, | Aug 16 2011 | Elwha LLC | Distillation of status data relating to regimen compliance responsive to the presence and absence of wireless signals relating to one or more threshold frequencies |
8816814, | Aug 16 2011 | Elwha LLC | Systematic distillation of status data responsive to whether or not a wireless signal has been received and relating to regimen compliance |
8874180, | Feb 28 2010 | Covidien LP | Ambient electromagnetic energy harvesting with wireless sensors |
9642556, | Jun 27 2014 | Intel Corporation | Subcutaneously implantable sensor devices and associated systems and methods |
9770189, | Aug 16 2011 | Elwha LLC | Systematic distillation of status data relating to regimen compliance |
Patent | Priority | Assignee | Title |
5944745, | Sep 25 1996 | Medtronic, Inc. | Implantable medical device capable of prioritizing diagnostic data and allocating memory for same |
5987352, | Jul 11 1996 | Medtronic, Inc | Minimally invasive implantable device for monitoring physiologic events |
6236882, | Jul 14 1999 | Medtronic, Inc | Noise rejection for monitoring ECG's |
6412490, | Jul 11 1996 | Medtronic, Inc. | Tool for insertion of implanatable monitoring device and method |
6526314, | Aug 20 1999 | Cardiac Pacemakers, Inc | Data management system for implantable cardiac device |
6684100, | Oct 31 2000 | Cardiac Pacemakers, Inc | Curvature based method for selecting features from an electrophysiologic signals for purpose of complex identification and classification |
7130678, | Apr 25 2003 | Medtronic, Inc.; Medtronic, Inc | Adaptive memory prioritization for implanted medical devices |
20050090719, |
Executed on | Assignor | Assignee | Conveyance | Frame | Reel | Doc |
Aug 19 2005 | Advanced Neuromodulation Systems, Inc. | (assignment on the face of the patent) | / | |||
Oct 19 2005 | VARRICHIO, ANTHONY J | ADVANCED NEUROMODULATION SYSTEMS, INC | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 016798 | /0557 |
Date | Maintenance Fee Events |
Jul 17 2012 | M1551: Payment of Maintenance Fee, 4th Year, Large Entity. |
Jul 27 2016 | M1552: Payment of Maintenance Fee, 8th Year, Large Entity. |
Jun 18 2020 | M1553: Payment of Maintenance Fee, 12th Year, Large Entity. |
Date | Maintenance Schedule |
Jan 27 2012 | 4 years fee payment window open |
Jul 27 2012 | 6 months grace period start (w surcharge) |
Jan 27 2013 | patent expiry (for year 4) |
Jan 27 2015 | 2 years to revive unintentionally abandoned end. (for year 4) |
Jan 27 2016 | 8 years fee payment window open |
Jul 27 2016 | 6 months grace period start (w surcharge) |
Jan 27 2017 | patent expiry (for year 8) |
Jan 27 2019 | 2 years to revive unintentionally abandoned end. (for year 8) |
Jan 27 2020 | 12 years fee payment window open |
Jul 27 2020 | 6 months grace period start (w surcharge) |
Jan 27 2021 | patent expiry (for year 12) |
Jan 27 2023 | 2 years to revive unintentionally abandoned end. (for year 12) |